600056.SS
600056.SS
CNE000000Q29
CHINA MEHECO GROUP CO LTD
Loading chart...

Company Profile

China Meheco Group Co., Ltd. operates in pharmaceutical industry in China and internationally. The company is involved in international trade of pharmaceuticals, including pharmaceutical preparations, drug substances, intermediates, medical devices, medical consumables, Chinese medicinal materials, and extracts; and pharmaceutical commerce business. It also provides supply chain services, such as sales agency, logistics and distribution, warehousing, equipment bidding, repair and maintenance, clinical value promotion, department planning, design, co-construction, operation and maintenance, SPD, and other services for various areas comprising vascular interventional therapy, non-interventional therapy, orthopedic implantation, neurosurgery, electrophysiology, pacemakers, extracorporeal circulation and blood purification, ophthalmology, and stomatology. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular and cerebrovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic and analgesics, and other therapeutic areas, as well as Chinese herbal materials and prepared slices. The company was founded in 1983 and is based in Beijing, China.

Related stocks

000028.SZ
000028.SZ • China
SINOPHARM ACCORD
19.96 CNY
1.83B USD 1Y -13.1%
301015.SZ
301015.SZ • China
BAHEAL MEDICAL
25.94 CNY
2.04B USD 1Y -4.5%
0874.HK
0874.HK • China
BAIYUNSHAN PH
13.21 HKD
2.74B USD 1Y -27.9%
600511.SS
600511.SS • China
CHINA NATIONAL MEDICINES CORP
26.67 CNY
3.01B USD 1Y -7.4%
600998.SS
600998.SS • China
JOINTOWN PHARMACEUTICAL GROUP C
5.08 CNY
3.83B USD 1Y +3.3%
000950.SZ
000950.SZ • China
CQP
5.34 CNY
1.37B USD 1Y +3.5%
200028.SZ
200028.SZ • China
ACCORD-B
12 HKD
936.21M USD 1Y -3.3%
600332.SS
600332.SS • China
GUANGZHOU BAIYUNSHAN PHARMACEUT
19.97 CNY
4.86B USD 1Y -22.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
39.9% p.a.
Max Drawdown (5Y)
-70.2%
Sharpe Ratio (5Y)
-0.01
Beta Factor
0.10
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -70.2% in the extended horizon.
ende